TIBCO Data Science/Statistica up to 14.0.0 Web Console cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in TIBCO Data Science and Statistica up to 14.0.0. It has been declared as problematic. This affects an unknown function of the component Web Console. Executing a manipulation can lead to cross site scripting. This vulnerability is tracked as CVE-2022-30575. The attack can be launched remotely. No exploit exists.
Details
A vulnerability classified as problematic was found in TIBCO Data Science and Statistica up to 14.0.0. This vulnerability affects some unknown processing of the component Web Console. The manipulation with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
The Web Console component of TIBCO Software Inc.'s TIBCO Data Science - Workbench, TIBCO Statistica, TIBCO Statistica - Estore Edition, and TIBCO Statistica Trial contains easily exploitable Reflected Cross Site Scripting (XSS) vulnerabilities that allow a low privileged attacker with network access to execute scripts targeting the affected system or the victim's local system. Affected releases are TIBCO Software Inc.'s TIBCO Data Science - Workbench: versions 14.0.0 and below, TIBCO Statistica: versions 14.0.0 and below, TIBCO Statistica - Estore Edition: versions 14.0.0 and below, and TIBCO Statistica Trial: versions 14.0.0 and below.
The weakness was disclosed 08/17/2022. The advisory is shared for download at tibco.com. This vulnerability was named CVE-2022-30575 since 05/11/2022. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.tibco.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.4VulDB Meta Temp Score: 5.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CNA Base Score: 7.3
CNA Vector (TIBCO Software Inc.): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
05/11/2022 🔍08/17/2022 🔍
08/17/2022 🔍
09/17/2022 🔍
Sources
Vendor: tibco.comAdvisory: tibco.com
Status: Confirmed
CVE: CVE-2022-30575 (🔍)
GCVE (CVE): GCVE-0-2022-30575
GCVE (VulDB): GCVE-100-206632
Entry
Created: 08/17/2022 10:59Updated: 09/17/2022 14:24
Changes: 08/17/2022 10:59 (48), 09/17/2022 14:24 (9)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.